L. Mary Smith - 13 Oct 2021 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role
Chief Development Officer
Signature
/s/ Francis I. Perier, Jr as Attorney-in-Fact
Issuer symbol
SWTX
Transactions as of
13 Oct 2021
Net transactions value
-$536,675
Form type
4
Filing time
13 Oct 2021, 20:24:00 UTC
Previous filing
14 Jul 2021
Next filing
10 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWTX Common Stock Options Exercise $23,000 +10,000 +6% $2.30* 177,511 13 Oct 2021 Direct F1
transaction SWTX Common Stock Sale $559,675 -10,000 -5.6% $55.97 167,511 13 Oct 2021 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWTX Stock Option (Right to Buy) Options Exercise $0 -10,000 -11% $0.000000 84,296 13 Oct 2021 Common Stock 10,000 $2.30 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option exercises and sale transactions reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $54.95 to $56.99, inclusive.
F3 Includes 27,304 restricted stock awards which are subject to forfeiture until they vest.
F4 This option began to vest and become exercisable in 48 equal monthly installments beginning on April 22, 2019.